Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 639 shares at $43.40 ($28K) on 2023-02-28, disclosed to the SEC on 2023-03-02.
Scheduled sale ($28k) by SVP, Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RARE | SELL | 2026-03-03 | $37K | — | Filing → |
| RARE | SELL | 2025-12-30 | $3K | — | Filing → |
| RARE | SELL | 2025-09-19 | $2K | — | Filing → |